Area of research
Oncology · Cancer Research
Research interest
Research interests include Global Cancer Incidence and Screening, Breast Cancer Treatment Studies, Multiple and Secondary Primary Cancers, and Economic and Financial Impacts of Cancer.
APOLLO11: a bio-data-driven model for clinical and translational research in lung cancer
Single Cancer Center Experience on Patient Blood Management Eligibility in Oncological Surgery.
Real-World Outcomes of Molecular Tumor Board Treatment Recommendations
Combining Clinician Expertise with Prompt Engineering enhances Small Language Models Reliability for Cancer Entity Recognition in Electronic Health Records
A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study
Survival and Health Care Burden of Children With Retinoblastoma in Europe
Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study
The observational EURACAN prospective clinical registry dedicated to epithelioid hemangioendothelioma: The protocol of an international and collaborative effort on an ultra-rare entity
Trends of use of drugs with suggested shortages and their alternatives across 52 real world data sources and 18 countries in Europe and North America
Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study
Automated classification of cancer morphology from Italian pathology reports using Natural Language Processing techniques: A rule-based approach.
Hypofractionated whole-breast radiotherapy in large breast size patients: is it really a resolved issue?
Kaposi sarcoma incidence, survival and trends: Data from the information network on rare cancers in Europe (RARECAREnet).
Differences in the management and survival of metastatic colorectal cancer in Europe. A population-based study
Differences in the management and survival of metastatic colorectal cancer in Europe. A population-based study.
Water and Soil Pollution: Ecological Environmental Study Methodologies Useful for Public Health Projects. A Literature Review.
Cancer cure for 32 cancer types: results from the EUROCARE-5 study.
Incidence and Survival of Patients With Conjunctival Melanoma in Europe.
Incidence and survival of rare cancers in the US and Europe.
Comorbidities, timing of treatments, and chemotherapy use influence outcomes in stage III colon cancer: A population-based European study.
Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study.
Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study
Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study.
High consistency between characteristics of primary intraductal breast cancer and subtype of subsequent ipsilateral invasive cancer.
Short-term survival after colorectal cancer in a screened versus unscreened population.
[Turn-over of non-tenured public health research personnel in an Italian public research institute (IRCCS).]
Geographical variability in survival of European children with central nervous system tumours
Time trends in axilla management among early breast cancer patients: Persisting major variation in clinical practice across European centers
Survival for oesophageal, stomach and small intestine cancers in Europe 1999–2007: Results from EUROCARE-5
On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999–2007 – Results from the EUROCARE-5 study